% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Yang:127820,
author = {R. Yang$^*$ and K. Pfütze$^*$ and M. Zucknick$^*$ and C.
Sutter and B. Wappenschmidt and F. Marme and B. Qu and K.
Cuk$^*$ and C. Engel and S. Schott and A. Schneeweiss and H.
Brenner$^*$ and R. Claus$^*$ and C. Plass$^*$ and P. Bugert
and M. Hoth and C. Sohn and R. Schmutzler and C. R. Bartram
and B. Burwinkel$^*$},
title = {{DNA} methylation array analyses identified breast
cancer-associated {HYAL}2 methylation in peripheral blood.},
journal = {International journal of cancer},
volume = {136},
number = {8},
issn = {0020-7136},
address = {Bognor Regis},
publisher = {Wiley-Liss},
reportid = {DKFZ-2017-03842},
pages = {1845 - 1855},
year = {2015},
abstract = {Breast cancer (BC) is the leading cause of cancer-related
mortality in women worldwide. Changes in DNA methylation in
peripheral blood could be associated with malignancy at
early stage. However, the BC-associated DNA methylation
signatures in peripheral blood were largely unknown. Here,
we performed a genome-wide methylation screening and
identified a BC-associated differentially methylated CpG
site cg27091787 in the hyaluronoglucosaminidase 2 gene
(HYAL2) (discovery round with 72 BC case and 24 controls: p
= 2.61 × 10(-9) adjusted for cell-type proportions). The
substantially decreased methylation of cg27091787 in BC
cases was confirmed in two validation rounds (first
validation round with 338 BC case and 507 controls: p <
0.0001; second validation round with 189 BC case and 189
controls: p < 0.0001). In addition to cg27091787, the
decreased methylation of a 650-bp CpG island shore of HYAL2
was also associated with increased risk of BC. Moreover, the
expression and methylation of HYAL2 were inversely
correlated with a p-value of 0.006. To note, the
BC-associated decreased HYAL2 methylation was replicated in
the T-cell fraction (p = 0.034). The cg27091787 methylation
level enabled a powerful discrimination of early-stage BC
cases (stages 0 and I) from healthy controls [area under
curve (AUC) = 0.89], and was robust for the detection of BC
in younger women as well (age < 50, AUC = 0.87). Our study
reveals a strong association between decreased HYAL2
methylation in peripheral blood and BC, and provides a
promising blood-based marker for the detection of early BC.},
keywords = {Biomarkers, Tumor (NLM Chemicals) / Cell Adhesion Molecules
(NLM Chemicals) / GPI-Linked Proteins (NLM Chemicals) /
Hyal2 protein, human (NLM Chemicals) /
Hyaluronoglucosaminidase (NLM Chemicals)},
cin = {C080 / C070 / G110 / C060 / C010},
ddc = {610},
cid = {I:(DE-He78)C080-20160331 / I:(DE-He78)C070-20160331 /
I:(DE-He78)G110-20160331 / I:(DE-He78)C060-20160331 /
I:(DE-He78)C010-20160331},
pnm = {313 - Cancer risk factors and prevention (POF3-313)},
pid = {G:(DE-HGF)POF3-313},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:25213452},
doi = {10.1002/ijc.29205},
url = {https://inrepo02.dkfz.de/record/127820},
}